JPRN-jRCTs012180018已完成3 期
Detection of recurrence after radiation therapy using C-11 methionine PET - Detection of recurrence after radiation therapy using C-11 methionine PET
Shigeru Yamaguchi0 个研究点目标入组 59 人开始时间: 2019年3月19日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 59
研究概览
简要总结
C-11 methionine-PET test using a new methionine-dedicated synthesizer is clinically useful in diagnosing recurrence of brain tumors after radiation therapy, and it can be easily performed.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •The patients with suspected recurrence of tumor more than a half year after radiation theray
- •The patients that enough diagnosis information is not obtained by the common imaging (CT, MRI)
- •The patients or the patients that a written agreement is obtained about participation of this study by legal representative
排除标准
- •The patients with a history of serious hypersensitivity for C-11 methionine or F-18 FDG.
- •A pregnant woman, nursing mother and the women who may be pregnant
- •The patients who participate in other trials
- •The patients who receive C-11 methioine PET within 90 days
- •The patients whom it is assumed overall status to have difficulty in application of the surgical treatment
- •The patients whom brain metastasis appeared outside of radiation fields
- •The patients that a primary tumor and other metastases caused exacerbation for a metastatic brain tumor remarkably
- •The patients whom it was multiple, and metastasis appeared for a primary cerebral tumor any place other than fields
- •When it is multiple, and a lesion with suspected recurrence of tumor develops independently than three places outside in fields or fields
- •In addition, the patients whom a study person in charge judged to be inadequate as subjects
研究者
相似试验
已完成
3 期
sefulness of using C-11 methionine PET in patient which suspected gliomagliomaJPRN-jRCTs012180017Yamaguchi Shigeru72
进行中（未招募）
2 期
Methionine PET/CT Studies In Patients With CancerBrain Tumors and/or Solid Tumors IncludingHigh Grade CNS TumorsMedulloblastomaLow Grade CNS TumorsEpendymomaNon Hodgkin LymphomaOsteosarcomaNeuroblastomaEwing SarcomaRhabdomyosarcomaBrain Stem GliomaHodgkin LymphomaCraniopharyngiomaNCT00840047St. Jude Children's Research Hospital503
Unknown
不适用
Pilot Viability of 11C-MET-PET as a Post-surgery Baseline Scan in High-grade GliomasGlioblastomaNCT02585219University Medical Center Groningen10
已完成
不适用
Prospective investigation of C-11 methionine PET/CT for bone tumorBone tumorJPRN-UMIN000020945Tokushima university hospital60
已完成
不适用
11C-Methionine PET as Prognostic Marker of GliomasGliomaNCT02518061Istituto Clinico Humanitas145